Risk-benefit assessments

被引：0
|
作者：
V. Yuvaraj
B. Krishnan
V. Murthy
S. Prasad
机构：
来源：
British Dental Journal | 2011年 / 210卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 151
相关论文
共 50 条
  • [41] Cardiovascular Risk-Benefit Profile of Sibutramine
    Scheen, A. J.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (05) : 321 - 334
  • [42] Best Practices in Risk-Benefit Analysis
    Verhagen, H.
    Tijhuis, M.
    Gunnlaugsdottir, H.
    Kalogeras, N.
    Leino, O.
    Lutejin, J.
    Magnusson, S.
    Odekerken, G.
    Pohjola, M.
    Tuomisto, J.
    Ueland, O.
    White, B.
    Holm, F.
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 : 415 - 415
  • [43] EVALUATING RISK-BENEFIT IN DRUG TRIALS
    LEVINE, MAH
    BROWMAN, G
    SACKETT, DL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 126 - 126
  • [44] NEW ANTIMALARIALS - A RISK-BENEFIT ANALYSIS
    NOSTEN, F
    PRICE, RN
    DRUG SAFETY, 1995, 12 (04) : 264 - 273
  • [45] A Risk-Benefit Assessment of Antileukotrienes in Asthma
    Lewis J. Smith
    Drug Safety, 1998, 19 : 205 - 218
  • [46] Nimesulide risk-benefit profile favourable
    Reactions Weekly, 2003, 963 (1) : 2 - 2
  • [47] Risk-Benefit Analysis of Bariatric Surgery
    Ludwig, Kaja
    Schneider-Koriath, Sylke
    Bernhardt, Joern
    Huettl, Thomas P.
    VISZERALMEDIZIN, 2010, 26 (01): : 21 - 25
  • [48] A Risk-Benefit Assessment of Amifostine in Cytoprotection
    May Mabro
    Sandrine Faivre
    Eric Raymond
    Drug Safety, 1999, 21 : 367 - 387
  • [49] CLOZAPINE - CALCULATING A RISK-BENEFIT RATIO
    LENERT, LA
    MORSS, S
    FAUSTMAN, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 215 - 215
  • [50] A RISK-BENEFIT ASSESSMENT OF RISPERIDONE IN SCHIZOPHRENIA
    CURTIS, VA
    KERWIN, RW
    DRUG SAFETY, 1995, 12 (02) : 139 - 145
12345